Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond

Keyphrases

• COVID-19 100%
• Clinical Evidence 100%
• Macrolides 100%
• Macrolide Antibiotics 100%
• Antiviral Properties 100%
• Erythromycin 50%
• Antibiotics 25%
• Viral Infection 25%
• Influenza Virus 25%
• Immunomodulatory Effect 25%
• Bacterial Infection 25%
• Antiviral Activity 25%
• Viral Respiratory Infections 25%
• Anti-inflammatory Properties 25%
• Clinical Benefit 25%
• Clinical Course 25%
• Direct Benefits 25%
• Azithromycin 25%
• Ebola Virus 25%
• Novel Antivirals 25%
• Pharmacological Properties 25%
• Nonbacterial 25%
• Associated Species 25%
• Clarithromycin 25%
• Zika Virus 25%
• Lactone Ring 25%
• Indirect Mechanism 25%
• Coronavirus 25%
• Antibiotic Activity 25%
• Antibacterial Activity 25%
• Streptomyces Sp 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Antibiotics 100%
• Antivirus Agent 100%
• Macrolide 100%
• Anti-Inflammatory Drug 33%
• Erythromycin 33%
• Clinical Study 16%
• Virus Infection 16%
• Antibacterial Activity 16%
• Antiviral Activity 16%
• Viral Respiratory Tract Infection 16%
• Influenza Virus 16%
• Lactone 16%
• Bacterial Infection 16%
• Streptomyces 16%
• Disease Course 16%
• Zika Virus 16%
• Ebola Virus 16%
• Azithromycin 16%
• Clarithromycin 16%
• Antimicrobial Agent 16%

INIS

• antibiotics 100%
• covid-19 100%
• reviews 50%
• drugs 50%
• inflammation 50%
• erythromycin 50%
• size 25%
• rings 25%
• coronaviruses 25%
• influenza viruses 25%
• lactones 25%
• ebola viruses 25%
• zika virus 25%
• streptomyces 25%